Ilaria Grazia Zizzari

Pubblicazioni

Titolo Pubblicato in Anno
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy FRONTIERS IN IMMUNOLOGY 2022
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study JOURNAL OF PERSONALIZED MEDICINE 2021
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis FRONTIERS IN IMMUNOLOGY 2021
Immunogenic cell death and immunomodulatory effects of cabozantinib FRONTIERS IN ONCOLOGY 2021
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment JOURNAL OF TRANSLATIONAL MEDICINE 2020
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring JOURNAL OF IMMUNOLOGY RESEARCH 2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1 FRONTIERS IN IMMUNOLOGY 2020
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma JOURNAL OF PERSONALIZED MEDICINE 2020
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma CANCERS 2020
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma HEPATOLOGY 2020
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL) CANCERS 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients JOURNAL OF PERSONALIZED MEDICINE 2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells EBIOMEDICINE 2020
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells ANNALS OF ONCOLOGY 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients JOURNAL OF PERSONALIZED MEDICINE 2020
Bevacizumab-based chemotherapy triggers Immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector T Cell Subsets JOURNAL OF CLINICAL MEDICINE 2019
Immunological backbone of uveal melanoma: is there a rationale for immunotherapy? CANCERS 2019
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab JOURNAL OF TRANSLATIONAL MEDICINE 2019
Immune profile of metastatic uveal melanoma during treatment with pembrolizumab JOURNAL OF CLINICAL ONCOLOGY 2019
HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES DIGESTIVE AND LIVER DISEASE 2019

ERC

  • LS6
  • LS6_2
  • LS6_3
  • LS6_11
  • LS7_2

Interessi di ricerca

Studio dei meccanismi di interazione tra tumore e cellule del sistema immunitario.

 

Analisi della fitness immunologica di pazienti con tumori solidi.

 

Vaccinazione anti-tumorale a base peptidica o mediante la somministrazione di cellule dendritiche (DC) autologhe pulsate con proteine ricombinanti o lisato tumorale.

 

Produzione di nuovi immunogeni per la terapia anti-tumore

 

Isolamento ex vivo di immunogeni per la vaccinazione anti-tumore.

 

Monitoraggio Immunologico nei trials clinici di Immunoterapia Sperimentale in Oncologia

Keywords

anticancer immunotherapy
anti-tumor immune response
biomarkers tumor
dendritic cells

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma